$0.900000
-0.24-26.66%
At close: Nov 20, 3:59 PM EDT
15 minutes delayed
Comments
Loading...
Acer Therapeutics Inc
ACEROTC
Acer Therapeutics Inc (OTC:ACER) Stock, Analyst Ratings, Price Targets, Forecasts
Acer Therapeutics Inc has a consensus price target of $3.33 based on the ratings of 4 analysts. The high is $7 issued by EF Hutton on March 20, 2023. The low is $1.5 issued by Roth Capital on September 1, 2023. The 3 most-recent analyst ratings were released by Roth Capital, Roth MKM, and HC Wainwright & Co. on September 1, 2023, September 1, 2023, and March 28, 2023, respectively. With an average price target of $5 between Roth Capital, Roth MKM, and HC Wainwright & Co., there's an implied 657.46% upside for Acer Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth Capital
Roth MKM
EF Hutton
1calculated from analyst ratings
Analyst Ratings for Acer Therapeutics Inc
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 09/05/2023 | Buy Now | — | HC Wainwright & Co. | Vernon Bernardino | — | Downgrade | Buy → Neutral | Get Alert |
| 09/01/2023 | Buy Now | 127.24% | Roth Capital | Jonathan Aschoff | → $1.5 | Downgrade | Buy → Neutral | Get Alert |
| 09/01/2023 | Buy Now | 127.24% | Roth MKM | Jonathan Aschoff | → $1.5 | Downgrade | Buy → Neutral | Get Alert |
| 03/28/2023 | Buy Now | 1717.91% | HC Wainwright & Co. | Vernon Bernardino | → $12 | Reiterates | → Buy | Get Alert |
| 03/20/2023 | Buy Now | 960.45% | EF Hutton | Constantine Davides | → $7 | Reiterates | → Buy | Get Alert |
| 02/02/2022 | Buy Now | 1263.43% | EF Hutton | Constantine Davides | → $9 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Acer Therapeutics Inc (ACER) stock?
The latest price target for Acer Therapeutics Inc (OTC:ACER) was reported by HC Wainwright & Co. on September 5, 2023. The analyst firm set a price target for $0.00 expecting ACER to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Acer Therapeutics Inc (ACER)?
The latest analyst rating for Acer Therapeutics Inc (OTC:ACER) was provided by HC Wainwright & Co., and Acer Therapeutics Inc downgraded their neutral rating.
When was the last upgrade for Acer Therapeutics Inc (ACER)?
There is no last upgrade for Acer Therapeutics Inc
When was the last downgrade for Acer Therapeutics Inc (ACER)?
The last downgrade for Acer Therapeutics Inc happened on September 5, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Acer Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Acer Therapeutics Inc (ACER)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acer Therapeutics Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acer Therapeutics Inc was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
Is the Analyst Rating Acer Therapeutics Inc (ACER) correct?
While ratings are subjective and will change, the latest Acer Therapeutics Inc (ACER) rating was a downgraded with a price target of $0.00 to $0.00. The current price Acer Therapeutics Inc (ACER) is trading at is $0.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.